Jane Street
RXST icon

Jane Street’s RxSight RXST Stock Holding History

Jane Street’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,900
Closed -$275K – 10721
2025
Q1 		$275K Sell
10,900
-28,100
-72% -$835K ﹤0.01% 7948
2024
Q4 		$1.34M Sell
39,000
-56,100
-59% -$2.53M ﹤0.01% 4855
2024
Q3 		$4.7M Buy
95,100
+84,400
+789% +$4.32M ﹤0.01% 2963
2024
Q2 		$644K Sell
10,700
-12,100
-53% -$691K ﹤0.01% 6607
2024
Q1 		$1.18M Buy
22,800
+7,800
+52% +$383K ﹤0.01% 5107
2023
Q4 		$605K Sell
15,000
-14,300
-49% -$419K ﹤0.01% 6441
2023
Q3 		$817K Buy
+29,300
New +$874K ﹤0.01% 5495

Other funds holding RXST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Jane Street's RXST Position: Q2 2026 in Review

Jane Street sold out of RxSight (RXST) in Q2 2026, closing a stake of 223,904 shares — an estimated $1.38M sold.

Jane Street first reported a position in RXST in Q1 2023 and held it in 12 quarters. The position peaked at $3.11M in Q2 2024. 152 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Jane Street reported no remaining RxSight position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 223,904 RxSight shares in Q2 2026, an estimated $1.38M.
  • Jane Street first reported a position in RxSight in Q1 2023 and held it in 12 quarters.
  • Jane Street's RxSight position peaked at $3.11M in Q2 2024.
  • 152 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.